Regular Article
Analysis of the Myc and Max Interaction Specificity with λ Repressor-HLH Domain Fusions

https://doi.org/10.1006/jmbi.1995.0241Get rights and content

Abstract

The basic helix-loop-helix domain (bHLH) is present in a large class of transcriptional regulators involved in developmental processes and oncogenesis. It determines DNA binding and specific homo- and heterodimeric protein associations, crucial for protein function. Myc and Max belong to a subset of HLH proteins, containing a leucine zipper (LZ) adjacent to the bHLH domain. They differ in dimerization and functional properties such as DNA binding and transcriptional activation, and their association is required for malignant transformation by Myc.

To analyze the interaction specificity of Myc and Max bHLH-LZ domains, we developed a simpleEscherichia coligenetic system, which uses the amino-terminal λ phage cI repressor as a reporter for dimerization and allows an easy detection of dimeric interactions. By reciprocal exchanges of different Myc and Max subdomains (helix 1, helix 2 and leucine zipper), we showed that the recognition specificity of Max homodimers as well as of Myc/Max heterodimers is entirely determined by the helix 2-leucine zipper region, the major role being played by the leucine zipper. The Myc LZ was found to prevent homodimeric interactions, thus explaining Myc inability to homodimerize efficiently. Moreover, we showed that the system is valid as well for reproducing the interaction of HLH proteins not containing a leucine zipper and that the chimerical proteins maintain sequence-specific DNA binding.

References (0)

Cited by (27)

  • BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis

    2007, Journal of Biological Chemistry
    Citation Excerpt :

    As with any point mutation, it has remained possible that the mutation interferes with other functions of c-MYC. For example, valine 394 is located within the helix-loop-helix domain, an area necessary for interaction with the transcription factor MAX, the ubiquitin ligase SKP2, and the histone acetyltransferase p300 (55–58). To fully validate the c-MYC/MIZ-1/apoptosis pathway, it was necessary to conclusively establish whether the V394D mutation selectively blocks MIZ-1 binding.

View all citing articles on Scopus
f1

Corresponding author

View full text